Medication info
Glovis Tablet

Glovis Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
Round white film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201406075 · Approved 2014.12.26

This product's status changed to Expired on 2024.12.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.) and prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
Usually, regardless of meals, administer 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dosage is the same when used in combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Diseases caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. However, the dosage may be increased to 4 tablets 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily, and increase the dose if necessary. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.) and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux
  • Mendelson's syndrome
  • postoperative ulcers
  • and ulcers caused by non-steroidal anti-inflammatory drugs.
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux. It is also administered to prevent Mendelson's syndrome before anesthesia and is effective in treating ulcers resulting from surgery and non-steroidal anti-inflammatory drugs (NSAIDs). It helps alleviate and treat symptoms of various gastrointestinal disorders.

How to take

Adult dose

Usually, regardless of meals, administer 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dosage is the same when used in combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Diseases caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. However, the dosage may be increased to 4 tablets 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily, and increase the dose if necessary. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Precautions

This medication should not be used by patients receiving dialysis treatment or those who are allergic to this drug or its components. It should also be avoided in patients with a history of acute porphyria, impaired kidney function, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, and premature infants or newborns. Patients who are on a potassium-restricted diet should also exercise caution. Patients with poor liver function, those with a history of drug allergies, the elderly, and patients with a history of kidney dysfunction should use this medication carefully. If taken with non-steroidal anti-inflammatory drugs, particularly elderly patients or those with a history of peptic ulcers should undergo regular examinations. This medication can mask symptoms of stomach cancer; thus, it should be used only after confirming that patients with gastric ulcers or recently emerged dyspepsia symptoms do not have malignant conditions. Patients with Helicobacter pylori infections and gastric/duodenal ulcers should undergo concomitant treatment to eradicate the bacteria. Caution is also needed when prescribing this medication to severely ill patients in the intensive care unit, hypophosphatemic patients, or those who have difficulty swallowing. Rarely, serious allergic reactions such as anaphylactic shock may occur upon using this medication, therefore it is advised to discontinue use and seek treatment immediately upon noticing symptoms. Allergic symptoms such as skin rashes, urticaria, angioedema, fever, and bronchospasm may also arise, requiring caution. Blood tests may show decreased white blood cell or platelet counts; if liver dysfunction or jaundice symptoms develop, the medication must be stopped immediately. Symptoms of cardiac rhythm abnormalities, gastrointestinal symptoms (nausea, vomiting, constipation, diarrhea, etc.), dizziness, drowsiness, mental confusion, and seizures have also been reported, necessitating caution. Symptoms such as gynecomastia, increased milk secretion, erectile dysfunction, and decreased libido may rarely occur. If accompanied by muscle pain or arthralgia, consider the possibility of rhabdomyolysis and consult healthcare professionals immediately. Skin-related adverse reactions such as rashes or hair loss have also been rarely reported. This medication should not be used long-term, and during treatment, careful observation of the progress and minimal dosing is recommended. Especially, the elderly or those with chronic lung disease, diabetes, or weakened immunity may have an increased risk of pneumonia, so caution is advised. If dizziness or drowsiness occurs after taking this medication, avoid driving or operating hazardous machinery. This medication can interact with other drugs, therefore it is important to inform healthcare professionals about any concurrent medications. Particularly, when taking anticoagulants such as warfarin, regular monitoring of blood coagulation test results is necessary. Additionally, when taken with certain antibiotics or antiepileptic drugs, antacids, dosing intervals should be spaced out to avoid affecting drug absorption. Pregnant or breastfeeding women should refrain from using this medication for safety, and safety and efficacy in children have not been established, thus its use is inadvisable. This medication may affect some clinical test results, so it's advisable to inform the healthcare professionals about this during examinations. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and if needed, removal via hemodialysis is possible. Finally, note that this medication can reduce gastric acid secretion, promoting bacterial growth in the gastrointestinal tract; thus, routine check-ups, including ophthalmic examinations, are needed during long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 48 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized fatigue
  • weakness
  • subcutaneous and mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sensation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorder
  • tics
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • mild erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and kept at a temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy and prevents deterioration.

Appearance and packaging

Appearance

Round white film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.